What's New
Front Page
One-Night Performance of Acclaimed Play UnRavelled Examines Art, Science, and Dementia
AFTD staff and Board members attended a performance of the play UnRavelled at the San Francisco Conservatory…
New York Times Magazine Chronicles a Family Living with the Threat of Genetic FTD
The cover story of the July 23 issue of the New York Times Magazine chronicles the experiences…
Guest Feature: Filmmaker and FTD Caregiver Shares Story of Love and Connection in “Pedacito de Carne”
Living with FTD can be exhausting, challenging, and at times deeply upsetting for people with a diagnosis,…
“Motivated by Love, Driven by Anger” – News Report Highlights Advocacy Efforts of Milwaukee Couple on FTD Journey
A June 30 report by the Milwaukee news station TMJ4 highlighted the advocacy efforts of church administrator…
AFTD and AviadoBio Discuss Therapeutic Treatment Protocols for FTD
AFTD recently spoke with AviadoBio Chief Executive Officer Lisa Deschamps about her colleagues’ work to develop a…
Groundbreaking Drug That Slows Progression of Alzheimer’s Receives Full FDA Approval
The U.S. Food and Drug Administration (FDA) has, for the first time, fully approved a drug that…
Help & Support: AFTD Resources for Kids and Teens
Unlike other types of dementia, FTD most often occurs in middle age, when many families have children…
Advancing Hope: AFTD and Packard Center for ALS Co-Host Innovative Interdisciplinary Workshop
The abnormal accumulation of the protein TDP-43 occurs in both FTD and amyotrophic lateral sclerosis (ALS), suggesting…
Aphasia Awareness Month: Resources and Guidance for Managing Primary Progressive Aphasia
June is Aphasia Awareness Month, bringing awareness of language-based disorders to people around the U.S. While many…
Watch Recordings from AFTD’s 2023 Education Conference
AFTD held its 2023 Education Conference on May 5, both in person in St. Louis and virtually….
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)